INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 146 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,845 | +959.7% | 531 | +532.1% | 0.00% | – |
| Q2 2023 | $929 | -85.7% | 84 | -82.6% | 0.00% | – |
| Q1 2023 | $6,487 | -53.7% | 483 | -51.2% | 0.00% | – |
| Q3 2022 | $14,000 | +600.0% | 989 | +678.7% | 0.00% | – |
| Q1 2022 | $2,000 | +100.0% | 127 | +126.8% | 0.00% | – |
| Q4 2021 | $1,000 | -80.0% | 56 | -71.7% | 0.00% | – |
| Q1 2021 | $5,000 | 0.0% | 198 | -7.5% | 0.00% | – |
| Q4 2020 | $5,000 | +400.0% | 214 | +872.7% | 0.00% | – |
| Q3 2020 | $1,000 | -75.0% | 22 | -75.0% | 0.00% | – |
| Q2 2020 | $4,000 | 0.0% | 88 | +203.4% | 0.00% | – |
| Q4 2019 | $4,000 | +100.0% | 29 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 29 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | -33.3% | 29 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | -97.5% | 29 | -97.6% | 0.00% | – |
| Q4 2018 | $121,000 | -17.1% | 1,201 | +3.9% | 0.00% | – |
| Q3 2018 | $146,000 | -2.0% | 1,156 | -34.9% | 0.00% | – |
| Q2 2018 | $149,000 | +38.0% | 1,775 | +1.4% | 0.00% | – |
| Q1 2018 | $108,000 | +881.8% | 1,751 | +821.6% | 0.00% | – |
| Q4 2017 | $11,000 | +175.0% | 190 | +156.8% | 0.00% | – |
| Q3 2017 | $4,000 | -66.7% | 74 | -26.0% | 0.00% | – |
| Q2 2017 | $12,000 | -90.8% | 100 | -91.3% | 0.00% | – |
| Q1 2017 | $130,000 | -62.0% | 1,153 | -44.4% | 0.00% | -100.0% |
| Q3 2016 | $342,000 | +245.5% | 2,075 | +198.1% | 0.00% | – |
| Q2 2016 | $99,000 | +1137.5% | 696 | +2075.0% | 0.00% | – |
| Q2 2014 | $8,000 | -98.3% | 32 | -97.8% | 0.00% | -100.0% |
| Q1 2014 | $484,000 | +1692.6% | 1,469 | +267.2% | 0.00% | – |
| Q4 2013 | $27,000 | -75.9% | 400 | -84.0% | 0.00% | -100.0% |
| Q2 2013 | $112,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
| Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
| Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
| Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
| Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
| BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
| ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
| DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
| Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
| Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |